Download the full-sized PDF
Permanent link (DOI): https://doi.org/10.7939/R33T9DC7R
This file is in the following communities:
|School of Public Health|
This file is in the following collections:
|Department of Public Health Sciences|
Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems Open Access
- Author or creator
- Additional contributors
- Type of item
- Research Material
Despite high expectations of economic returns, large investments in regenerative medicine technology have yet to materialize, partly due to a lack of proven business and investment models, regulatory hurdles, and a greater focus on cost-effectiveness for reimbursement decisions by payors. Adoption of new economic modeling methods will better link investment decisions to value-based criteria of health systems.
- Date created
- License information
- This is a copy of an article published in Stem Cells and Development © 2013 copyright Mary Ann Liebert, Inc.; Stem Cells and Development is available online at: http://online.liebertpub.com.
- Citation for previous publication
Bubela Tania and McCabe Christopher. "Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems" Stem Cells and Development. December 2013, 22(S1): 89-93. doi:10.1089/scd.2013.0398.
- Link to related item
- Date Uploaded
- Date Modified
- Audit Status
- Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 345021
Last modified: 2015:10:12 18:38:13-06:00
Filename: Stem Cells & Development 22(S1) 2013.pdf
Original checksum: 97749beda274fcf9b6609eadb702420e
Well formed: true
Status message: File header gives version as 1.4, but catalog dictionary gives version as 1.3
File title: Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems
File author: Bubela Tania and McCabe Christopher
Page count: 5